Order Article Reprints

De Santis P, Sanna V, Perrone M, Guarini C, Santoro AN, Laface C, Carrozzo D, Oliva GR, Fancellu A, Fedele P. Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading? Journal of Clinical Medicine. 2023; 12(23):7325. https://doi.org/10.3390/jcm12237325

De Santis, Pierluigi, Valeria Sanna, Martina Perrone, Chiara Guarini, Anna Natalizia Santoro, Carmelo Laface, Daniela Carrozzo, Gaia Rachele Oliva, Alessandro Fancellu, and Palma Fedele. 2023. "Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?" Journal of Clinical Medicine 12, no. 23: 7325. https://doi.org/10.3390/jcm12237325

De Santis, P., Sanna, V., Perrone, M., Guarini, C., Santoro, A. N., Laface, C., Carrozzo, D., Oliva, G. R., Fancellu, A., & Fedele, P. (2023). Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading? Journal of Clinical Medicine, 12(23), 7325. https://doi.org/10.3390/jcm12237325